
Lawsuits claiming Ozempic, other GLP-1s led to blindness become second mass litigation over the drugs
DEC 15 (Reuters) – A federal judicial panel said Monday it would centralize a growing number of lawsuits against Novo Nordisk and Eli Lilly alleging patients lost some or all







